Drug
RPH201 clinical trials
Also written RPh201.
- studies test it
- 8
- open now
- 0
- in phase 3
- 0
- first study started
- 2011
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2011 (3)
| Year | Studies |
|---|---|
| 2011 | 3 |
| 2012 | 2 |
| 2014 | 1 |
| 2018 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 2
Regenera Pharma Ltd (6) · Hadassah Medical Organization (2)
Studies
Open first, then newest update. How each study uses RPH201 is read from its arms, and is right about nine times in ten.
Testing it · 8
- Efficacy & Safety of RPh201 Treatment in Patients With Previous Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)TerminatedPhase 2Regenera Pharma LtdNCT03547206Written as RPh201 Cohort A
- A Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular DiseaseCompletedPhase 2Regenera Pharma LtdNCT03462121Written as RPh201
- A Randomized SAD and MAD Study Evaluating the Safety and Tolerability of RPh201 in Healthy Subjects and in Adults With Alzheimer's DiseaseCompletedPhase 1/2Regenera Pharma LtdNCT01513967Written as RPh201, botanical drug product
- Safety and Efficacy Study of RPh201 Treatment of Ischemic Optic Neuropathy (ION).CompletedPhase 2Regenera Pharma LtdNCT02045212Written as RPh201
- Efficacy of RPh201 Applied Topically for the Treatment of Hard to Heal Chronic Ulcerated WoundsTerminatedPhase 1/2Regenera Pharma LtdNCT01429519Written as RPh201, botanical drug product
- The Impact of RPh201 on Chronic Vegetative State (CVS): fMRI StudySuspendedPhase 1Hadassah Medical OrganizationNCT01438684Written as RPh201
- Trial To Evaluate RPh201 In Treatment Of Partial Thickness BurnWithdrawnPhase 1/2Regenera Pharma LtdNCT01455480Written as RPh201, botanical drug product
- The Impact of RPh201 on CVS Patients: Clinical and fMRI MeasurementsWithdrawnPhase 1/2Hadassah Medical OrganizationNCT01417299Written as RPh201